562.18MMarket Cap
4.51P/E TTM
Zevra Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Zevra Therapeutics Inc is 7.58, ranking 97 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 4.51, which is 256.47% below the recent high of 16.08 and 3169.31% above the recent low of -138.42.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.